Bullish harmonic. Pattern in combination of low float stock such as KMPH is very bullish setup especially since the stock has been hovering around previous highest volume day of 1M shares traded. the stock has been hovering around 900k and reluctant to break 1M but the tutes are getting anxious as investor Samuel Braun decided to add to his position and steal...
Wouldn't be surprised to see this stock break all time highs in next few months and in the next 12-months $50+. * Key notes: 2nd generation Covid Vaccine sponsored by NIAID that's being conducted through infectious diseases clinical research consortium (IDCRC). Established collaboration with Gilead Sciences to develop a vaccine-based immunotherapy as part of...
Recently approved ADHD med. CEO Travis Mickle helped develop current market leader Vyvance (also ADHD med) and now with a new and improved iteration (Aztrazyris) . Also worth to note Mickle sold his previous company (new river) to shire then shire was bought out by Takeda for bucku bucks and now Mickle is working with ex-shire CEO to bring this baby to market!...
VBIV CEO Baxter said on a feb 5 2021 podcast that human trials were to begin in the next couple of weeks for their single dose monovalent covid vaccine vbi-2902, which received $56 Million from Canada to produce a vaccine. Today moderna announced forecasted sales of ~$18 Billion just from covid vaccine sales. Once VBi announces initiation of human trials for the...
Super bullish, breaking 6-month high. Python Algo signaling major move to upside. Fibs agree going over $12+
Consolidation at LQDA in range of their all time low after FDA issued the biotech company a CRL due to COVID restrictions. After speaking with regulators at the FDA, The company expressed this CRL had nothing to do with the underlying data. Options activity has been healthy. I believe price will increase from here, which is why I have started a position and...
ES and NQ @ critical technical levels with news of further shutdowns. Here I'd like everyone to take another look at what I am presenting. In this chart, I have flipped the ES1! chart upside down so if you're not used to looking for trades in both directions (i.e short and long)- this may make it easier for you. If you look at the chart as I present *dont look at...
Watch this stock move as new countries, states consider/announce shutdowns.
Bullish Harmonic Gartley on 2-day chart is pretty strong pattern for the bulls.
I’m sharing this as an impromptu for this upcoming weeks Earnings regarding what stock looks like pre-R/S, being this severely damaged. I look forward to seeing how management goes forward with addressing the company’s current financial state. Technicals : - Stock at bottom of wedge = Bullish, for bounce play, especially “good” on news. - Weekly RSI...
Check out my indicator I programmed top and bottom with green. Good luck friends!
Many are saying it but earnings will shine light on DARK places of the future US economy. Elliott wave -> corrective ascending triangle. i see what most of you see but am having difficulty with that inner wave iii of my (C) wave. As the rule states, wave 3 can't be the shortest. in fact wave 3 of 3's are usually the longest. The count on this inner 3rd wave's,...
Double bottom Testing resistance for potential breakout.
EYPT chart is building up for another run. Potential catalyst before year end with an sNDA for Short Duration Yutiq. accumulation has been slow and steady indicating EYPT oversold conditions. Technical's: weekly chart --> Harmonic Gartley (bounced off significant support level) and been in uptrend since. Symmetrical Triangle/ Breakout setup has been known...
Biotech buyouts have been very strong, especially with Gene therapy stocks as of late. Bounced off Lower end of channel Gartley pattern bounced off 1.618 fib extension along with important reversal leg of Elliott Wave Theory. if price holds inside the lower end of the channel there is a potential move back up and test the gap. looking for nice $0.40+ swing...
BLCM has been in continuous long-term downtrend since IPO. Stock price has been showing signs of a bo... Click here to read the rest of my analysis on BLCM. Disclosure: I am long BLCM. This is not a recommendation to buy/sell as I am NOT a financial advisor. Please do your homework before investing.
MRKR showing signs of life after testing a key Fibonacci level of support. Chart: Double bottom CCI moved positive (inferring a nice loading zone) MS Signal is showing "Over-Sold" conditions Key *Support needs to hold $3.80 Key *Resistance at $4.53 then $5.29 (highlighted in green shaded area) Disclosure: I do not own MRKR. I may buy/ sell within...
Friday, October 11, 2019 ADVM is a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, ADVM is set to present additional clinical data for the first cohort of patients (n=6) in the OPTIC phase 1 clinical trial of ADVM-022, intra-vitreal injection gene therapy in wet age-related macular degeneration (wet AMD) at the...